A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

3.6K views

DOI:

10.3791/64742

May 5th, 2023

* These authors contributed equally

In This Article

Erratum Notice

Important: There has been an erratum issued for this article. View Erratum Notice

Summary

This protocol describes the isolation of pulmonary interstitial macrophages (IMs) and their adoptive transfer after IL-33 stimulation of the lung alveoli in a mouse model, which can facilitate the in vivo study of idiopathic pulmonary fibrosis (IPF).

Abstract

The inflammatory response caused by early lung injury is one of the important causes of the development of idiopathic pulmonary fibrosis (IPF), which is accompanied by the activation of inflammatory cells such as macrophages and neutrophils, as well as the release of inflammatory factors including TNF-α, IL-1β, and IL-6. Early inflammation caused by activated pulmonary interstitial macrophages (IMs) in response to IL-33 stimulation is known to play a vital role in the pathological process of IPF. This protocol describes the adoptive transfer of IMs stimulated by IL-33 into the lungs of mice to study IPF development. It involves the isolation and culture of primary IMs from host mouse lungs, followed by the adoptive transfer of stimulated IMs into the alveoli of bleomycin (BLM)-induced IPF recipient mice (which have been previously depleted of alveolar macrophages by treatment with clodronate liposomes), and the pathological evaluation of those mice. The representative results show that the adoptive transfer of IL-33-stimulated macrophages aggravates pulmonary fibrosis in mice, suggesting that the establishment of the macrophage adoptive transfer experiment is a good technical means to study IPF pathology.

Introduction

Idiopathic pulmonary fibrosis (IPF) is a diffuse pulmonary inflammatory disease caused by many factors1. In the cytokine microenvironment of the Th1 and Th2 immune response, macrophages can be polarized into classically activated macrophages (M1) and alternatively activated macrophages (M2). Lipopolysaccharides (LPS) or the cytokine IFN- γ induce M1 macrophages to polarize and produce pro-inflammatory cytokines, including iNOS, IL-1, IL-6, TNF-α, and IL-12. In contrast, the type II cytokines IL-4 and IL-13 drive the polarization of M2 macrophages, which can produce different fibroblast growth-promoting factors, such as TGF-β and ....

Access restricted. Please log in or start a trial to view this content.

Protocol

All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals. All the animal experiments were approved by the Experimental Animal Welfare Ethics committee of Jiangnan University (JN No. 20211130m1720615[501]).

NOTE: In total, 10 male C57BL/6 mice aged 6-8 weeks old and weighing 20-25 g were used in this study. The three experimental groups in the study included three recipient mice each, and one host mouse was used for the IM isolation.

1. Depletion of mouse pulmonary macrophages

  1. Take out the vial of clodronate liposomes (see

Access restricted. Please log in or start a trial to view this content.

Results

The protocol used here is summarized in the flowchart in Figure 1. The inhalation of clodronate liposomes through the nose (Figure 2) was used to deplete the pulmonary macrophages of adult C57BL/6 mice, and this produced a good recipient mouse model. Pulmonary IMs were isolated from another untreated (host) mouse (Figure 3A,B) and cultured in vitro. The isolated macrophages were stimulated with IL-33 for 24.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This study provides an effective method to deplete, isolate, culture, and transfer macrophages, which can help in studying the mechanisms of pulmonary fibrosis in mice. There are many methods for mouse macrophage depletion, such as tracheal administration, tail vein injection, and nasal inhalation11. This study optimized the nasal inhalation method, which is simple to operate and can effectively deplete pulmonary macrophages8,9. After the .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no competing financial interests.

Acknowledgements

The authors acknowledge the Special Topic of Laboratory Management of Jiangnan University: Construction of Digital Slice Library Based on Pathological Specimens (JDSYS202223) and the National Natural Science Foundation of China (81800065).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
 DMEMLife technologies Biotechnology,USA1508012
Arterial indwelling needleB Braun Melsingen AG,Germany21G15G8393
BD Accuri C6 PlusBecton Dickinson,USA
BleomycinBiotang, USAAb9465
Carbon dioxide incubatorThermo Forma, USAThermo Forma370
CD11bR&D Systems,USA1124F
CD11cR&D Systems,USAN418
Cell culture dishThermo Forma, USA174926
Clodronate liposomes Clodronate liposomes,NetherlandsCI-150-150
Collagenase ASigma-Aldrich, USA10103578001
F4/80R&D Systems,USA521204
Falcon Cell StrainerBecton,Dickinson and Company, USA352340
Fetal bovine serum (FBS)Life technologies,USA1047571
Hematoxylin Eosin Nanjing Jiancheng Technology,China06-570
LightCycler 480 PCR detection systemRoche, USA
Murine recombinant factor IL-33Peprotech, USA210-33
Nikon microscopeNikon Corporation, Japan941185
Penicillin, streptomycinLife technologies,USA877113
Phosphate buffer (PBS)Guangdong Huankai Microbial Technology ,China1535882
RBC lysis bufferBeyotime Biotechnology Company,ChinaC3702
RNA IsolaterVazyme company,ChinaR401-01-AATotal RNA extraction reagent
RWD Inhalation Anesthesia MachineShenzhen Rayward Life Technology ,ChinaR500
Semi-automatic paraffin slicerLeica, GermanyLeicaRM2245
SYBR Premix Ex TaqTakara, Japan410800
Trypsin 0.25%Life Technologies, USA1627172

References

  1. Heukels, P., Moor, C. C., vonder Thüsen, J. H., Wijsenbeek, M. S., Kool, M. Inflammation and immunity in IPF pathogenesis and treatment. Respiratory Medicine. 147, 79-91 (2019).
  2. Zhang, Y., Zhang, Y., Li, X., Zhang, M., Lv, J. Microarray an....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Erratum


Formal Correction: Erratum: Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Posted by JoVE Editors on 1/01/1970. Citeable Link.

An erratum was issued for: Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo. The Protocol section was updated.

Step 2.1 of the Protocol was updated from:

Anesthetize the host mouse with 3% isoflurane, and then euthanize it by cervical dislocation. Disinfect the skin of the euthanized mouse with 75% alcohol and iodine. Use scissors to cut through the skin and expose the cardiopulmonary tissue

to:

Anesthetize the host mouse with an intraperitoneal injection of Ketamine (120 mg/kg) and Xylazine (16 mg/kg). Confirm the depth of anesthesia via loss of the toe pinch reflex. Apply veterinary ointment to both eyes to prevent dryness under anesthesia. Then, disinfect the skin of the anesthetized mouse with 75% alcohol and iodine. Use scissors to cut through the skin and expose the cardiopulmonary tissue

Tags

IL 33 StimulationPulmonary MacrophagesBleomycin Mouse ModelInterstitial MacrophagesClodronate LiposomesLung Tissue IsolationFibrosis MarkersAshcroft Score